Lanqing Li

1.2k total citations · 2 hit papers
44 papers, 887 citations indexed

About

Lanqing Li is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Lanqing Li has authored 44 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Lanqing Li's work include Microbial Natural Products and Biosynthesis (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Hepatitis B Virus Studies (4 papers). Lanqing Li is often cited by papers focused on Microbial Natural Products and Biosynthesis (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Hepatitis B Virus Studies (4 papers). Lanqing Li collaborates with scholars based in China, United States and Pakistan. Lanqing Li's co-authors include Haiying Xu, Kang Xu, Linghang Qu, Chunli Wang, Shunshun Wang, Kang Xu, Zijun Wang, Xianqiong Liu, Zhijin Fan and Liming Nie and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and Bioresource Technology.

In The Last Decade

Lanqing Li

42 papers receiving 877 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites

2023 121 citations Haiying Xu, Lanqing Li et al. Phytomedicine profile →
Lumican promotes calcific aortic valve disease through H3 histone lactylation

2024 62 citations Yuming Huang, Chunli Wang et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lanqing Li China	17	435	181	147	93	75	44	887
Avtar S. Meena United States	20	517 1.2×	156 0.9×	170 1.2×	66 0.7×	138 1.8×	36	1.2k
Ziyu Jiang China	16	354 0.8×	127 0.7×	131 0.9×	56 0.6×	107 1.4×	37	829
Muhammad Zahid Qureshi Pakistan	17	571 1.3×	146 0.8×	268 1.8×	72 0.8×	60 0.8×	76	1.1k
Mingjun Wu China	15	385 0.9×	86 0.5×	84 0.6×	92 1.0×	46 0.6×	37	752
Nobendu Mukerjee India	19	530 1.2×	96 0.5×	179 1.2×	74 0.8×	63 0.8×	94	1.1k
Hongmei Hu China	19	436 1.0×	110 0.6×	82 0.6×	131 1.4×	42 0.6×	81	1.1k
Hashem Khanbabaei Iran	18	583 1.3×	129 0.7×	279 1.9×	88 0.9×	97 1.3×	29	1.1k
Wenhe Zhu China	15	304 0.7×	147 0.8×	87 0.6×	45 0.5×	43 0.6×	41	703
Kuan Liu China	12	430 1.0×	107 0.6×	87 0.6×	85 0.9×	52 0.7×	29	1.0k
Qiao Zhang China	20	767 1.8×	138 0.8×	174 1.2×	131 1.4×	73 1.0×	77	1.2k

Countries citing papers authored by Lanqing Li

Since Specialization

Citations

This map shows the geographic impact of Lanqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanqing Li more than expected).

Fields of papers citing papers by Lanqing Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanqing Li. The network helps show where Lanqing Li may publish in the future.

Co-authorship network of co-authors of Lanqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lanqing Li. A scholar is included among the top collaborators of Lanqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanqing Li. Lanqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Jinhui, Lulu Jiang, Lanqing Li, & Wen‐Hua Chen. (2025). Environmentally sensitive fluorescent probes for the visualization of selective proteins: Recent progress and biomedical applications. European Journal of Medicinal Chemistry. 300. 118158–118158. 2 indexed citations

Chen, Li, et al.. (2025). Design, synthesis and biological evaluation of Golgi-targeting anion transporters as inducers of Golgiphagy and apoptosis in cancer cells. European Journal of Medicinal Chemistry. 290. 117519–117519. 1 indexed citations

Chen, Lian, Zhonghui Lu, Yunfei Hu, et al.. (2025). Dual Induction of Ferroptosis and Apoptosis by Triazolopyrimidinyl Derivatives: Design, Synthesis, and Biological Evaluation for Their Anticancer Efficacy via Calcium/Calmodulin Signaling and Mitochondrial Impairment. Journal of Medicinal Chemistry. 68(21). 23024–23049. 1 indexed citations

Dong, Hui, et al.. (2025). Discovery of fluorescent and theranostic probes for glycogen synthase kinase-3β in living cells and brain tissues: Detection and imaging in models of Alzheimer's disease. European Journal of Medicinal Chemistry. 291. 117639–117639. 2 indexed citations

Lao, Lixing, et al.. (2025). Anti-Alzheimer effects of an HDAC6 inhibitor, WY118, alone and in combination of lithium chloride: Synergistic suppression of ferroptosis via the modulation of tau phosphorylation and MAPK signaling. European Journal of Pharmacology. 997. 177605–177605. 2 indexed citations

Huang, Yuming, Chunli Wang, Tingwen Zhou, et al.. (2024). Lumican promotes calcific aortic valve disease through H3 histone lactylation. European Heart Journal. 45(37). 3871–3885. 62 indexed citations breakdown →

Zhou, Jing, et al.. (2024). Nucleos(t)ide analogs to treat patients with positive hepatitis B virus deoxyribonucleic acid and normal alanine transaminase: protocol for an open-label single-center randomized parallel controlled trial. Trials. 25(1). 652–652.

Fan, Ping, Lanqing Li, & En‐Qiang Chen. (2023). The urgency to expand the antiviral indications of general chronic hepatitis B patients. Frontiers in Medicine. 10. 1165891–1165891. 1 indexed citations

Long, Hongping, et al.. (2023). Two New Compounds from the Fungus Xylaria nigripes. Molecules. 28(2). 508–508. 8 indexed citations

10.

Li, Yanli, Qing K. Wang, Tian Chen, et al.. (2023). Multi-Biomarkers Panel in Identifying Benign and Malignant Lung Diseases and Pathological Types of Lung Cancer. Journal of Cancer. 14(10). 1904–1912. 4 indexed citations

11.

Li, Lanqing, Jing Zhou, Yujing Li, et al.. (2023). Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study. Frontiers in Pharmacology. 14. 1165990–1165990. 9 indexed citations

12.

Xu, Haiying, Lanqing Li, Shunshun Wang, et al.. (2023). Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites. Phytomedicine. 118. 154940–154940. 121 indexed citations breakdown →

13.

Xu, Haiying, et al.. (2022). Quality assessment of processed Eucommiae Cortex based on the color and tensile force. Medicine in Novel Technology and Devices. 16. 100167–100167. 4 indexed citations

14.

Xu, Haiying, Lanqing Li, Linghang Qu, et al.. (2022). Atractylenolide‐1 affects glycolysis/gluconeogenesis by downregulating the expression of TPI1 and GPI to inhibit the proliferation and invasion of human triple‐negative breast cancer cells. Phytotherapy Research. 37(3). 820–833. 14 indexed citations

15.

Li, Lanqing, et al.. (2022). A new strategy for osteoarthritis therapy: Inhibition of glycolysis. Frontiers in Pharmacology. 13. 1057229–1057229. 38 indexed citations

16.

Li, Lanqing, Xiaoqiang Wang, Haiying Xu, Xianqiong Liu, & Kang Xu. (2022). Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma. Frontiers in Molecular Biosciences. 9. 947208–947208. 19 indexed citations

17.

Li, Jing, Lanqing Li, Hongping Long, et al.. (2021). Xylarinaps A–E, five pairs of naphthalenone derivatives with neuroprotective activities from Xylaria nigripes. Phytochemistry. 186. 112729–112729. 13 indexed citations

18.

Feng, Fan, Lianhong Pan, Jiaqin Wu, et al.. (2021). Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo. International Journal of Biological Sciences. 17(15). 4340–4352. 42 indexed citations

19.

Nie, Xiaobo, Haisheng Wang, Xiaoyun Wei, et al.. (2021). LRP5 Promotes Gastric Cancer via Activating Canonical Wnt/β-Catenin and Glycolysis Pathways. American Journal Of Pathology. 192(3). 503–517. 24 indexed citations

20.

Ewald, Sandra J., Yi-Yang Lien, Lanqing Li, & Logan Johnson. (1996). B-haplotype control of CD4/CD8 subsets and TCR Vβ usage in chicken T lymphocytes. Veterinary Immunology and Immunopathology. 53(3-4). 285–301. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact